Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

17 Jan 2013 13:48

RNS Number : 8076V
Maven Income & Growth VCT PLC
17 January 2013
 



Interim Management Statement

 

Maven Income and Growth VCT PLC (the Company) - quarter ended 30 November 2012

 

This Interim Management Statement, for the quarter ended 30 November 2012, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 December 2012 to the date of this announcement. This statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net Asset Value (NAV)1 of 70.0p per share at 30 November 2012, compared to 69.5p per share at 31 August 2012;

·; NAV total return2 of 117.6p per share at 30 November 2012, compared to 117.1p per share at 31 August 2012;

·; 183,000 Ordinary Shares bought back for cancellation during the quarter; and

·; Interim dividend of 2.0p per share in respect of the year ending 28 February 2013, paid on 7 December 2012.

 

1The NAV is unaudited, includes the value of the interim dividend in respect of the year ending 28 February 2013 and reflects the closing bid price of quoted securities as at 30 November 2012. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 August 2012, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 30 November 2012, a total of £87,330 was invested in two unlisted companies. Aggregate proceeds of £1,756,262 were received from the disposal of holdings in six unlisted companies, against a total cost of £1,143,008.

 

3.

Recent developments

 

Between 1 December 2012 and the date of this Statement, investments totalling £2,054,621 were made in six unlisted companies; £3,497,644 was invested in UK government securities; £113,521 of loan notes were repaid by an unlisted company; £64,756 of deferred consideration was received from the previous disposal of an unlisted holding; proceeds of £4,068 were received from the disposal of two AIM holdings against cost of £7,077; and the sale of UK government securities generated proceeds of £4,351,000 against cost of £4,344,841.

 

Other than as described above and any changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 September 2012 to 30 November 2012, or in the period from 1 December 2012 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

17 January 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUQCGUPWGWM
Date   Source Headline
7th Jun 20234:21 pmRNSAnnual Financial Report
2nd Jun 20239:39 amRNSIssue of Equity
1st Jun 202312:18 pmRNSNet Asset Value(s)
26th May 20233:53 pmRNSTransaction in Own Shares
24th May 202310:52 amRNSUnaudited NAV and Proposed Final Dividend
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
5th Apr 202312:33 pmRNSDirector/PDMR Shareholding
5th Apr 202312:26 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
3rd Mar 202310:37 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 20239:47 amRNSIssue of Equity
21st Feb 20234:39 pmRNSTransaction in Own Shares
6th Feb 20234:23 pmRNSNet Asset Value(s)
2nd Dec 20229:30 amRNSIssue of Equity
25th Nov 202212:36 pmRNSStatement re Dividend Investment Scheme
9th Nov 20222:34 pmRNSResult of General Meeting
4th Nov 202211:15 amRNSHalf-year Report
26th Oct 20223:50 pmRNSTransaction in Own Shares
14th Oct 20223:33 pmRNSNet Asset Value and Interim Dividend
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
5th Aug 20224:39 pmRNSTransaction in Own Shares
15th Jul 202211:08 amRNSIssue of Equity
11th Jul 20223:12 pmRNSStatement re Dividend Investment Scheme
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
8th Jul 20222:36 pmRNSNet Asset Value(s)
7th Jul 20222:34 pmRNSResult of AGM
8th Jun 20222:12 pmRNSAnnual Financial Report
29th Apr 20222:28 pmRNSTransaction in Own Shares
27th Apr 20224:04 pmRNSTransaction in Own Shares
21st Apr 202211:22 amRNSStatement re NAV and Proposed Final Dividend
25th Jan 20224:04 pmRNSTransaction in Own Shares
21st Jan 20223:15 pmRNSNet Asset Value(s)
3rd Dec 20219:48 amRNSIssue of Equity
26th Nov 20219:53 amRNSStatement re Dividend Investment Scheme
12th Nov 20214:31 pmRNSHalf-year Report
11th Nov 20214:23 pmRNSTransaction in Own Shares
9th Nov 20211:33 pmRNSTransaction in Own Shares
27th Oct 20214:44 pmRNSNet Asset Value and Interim Dividend
20th Sep 20214:57 pmRNSStatement re Change of Registrar
16th Jul 202110:04 amRNSIssue of Equity
12th Jul 20214:28 pmRNSStatement re Dividend Investment Scheme
7th Jul 20213:32 pmRNSNet Asset Value(s)
7th Jul 202112:37 pmRNSResult of AGM
4th Jun 20214:16 pmRNSAnnual Financial Report
4th May 20213:37 pmRNSIssue of Equity
20th Apr 20214:56 pmRNSTransaction in Own Shares
16th Apr 20214:40 pmRNSNet Asset Value and Proposed Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.